International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.

Abstract

Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues.

• Authors: Camille N Kotton, Deepali Kumar, Angela M Caliendo, Anders Asberg, Sunwen Chou, David R Snydman, Upton Allen, Atul Humar, Transplantation Society International CMV Consensus Group
• Journal: Transplantation (Transplantation) Vol. 89 Issue 7 Pg. 779-95 (Apr 15 2010) ISSN: 1534-6080 [Electronic] United States
• PMID: 20224515 (Publication Type: Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't)

Chemical References

• Antiviral Agents
• Cytomegalovirus Vaccines
• Immunosuppressive Agents

Topics

• Adult
• Antiviral Agents (therapeutic use)
• Child
• Consensus
• Consensus Development Conferences as Topic
• Cytomegalovirus Infections (diagnosis, drug therapy, immunology, prevention & control)
• Cytomegalovirus Vaccines
• Drug Resistance, Viral
• Evidence-Based Medicine
• Humans
• Immunosuppressive Agents (adverse effects)
• International Cooperation
• Organ Transplantation (adverse effects)
• Risk Assessment
• Risk Factors
• Treatment Outcome